FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362637893> ?p ?o ?g. }

• W4362637893 endingPage "101833" @default.
• W4362637893 startingPage "101833" @default.
• W4362637893 abstract "To prevent hypoglycemic episodes, the management of insulin therapy against post-transplant diabetes mellitus (PTDM) is important. We compared glargine (long-acting insulin) versus NPH isophane (intermediate-acting insulin) as an armamentarium against PTDM. Indeed, the study evaluated PTDM patients with hypoglycemic episodes treated with isophane or glargine. We evaluated a total number of 231 living-donor renal transplant recipients with PTDM of age ≥ 18 years admitted to the hospital between January 2017 and September 2021. However, patients taking hypoglycemic agents before transplantation were excluded from this study. Out of 231 patients, 52 (22.15%) suffered from PTDM out of whom 26 were treated with glargine or isophane. After applying exclusion criteria, out of 52 PTDM patients 23 were included in the study: 13 PTDM patients were treated with glargine, whereas 10 PTDM patients with isophane. Our analysis revealed 12 episodes of hypoglycemia in glargine-treated PTDM patients compared to 3 in isophane-treated PTDM patients (p = 0.056). Clinically, 9 out of 15 hypoglycemic episodes were nocturnal (60%). Furthermore, no other risk factors were observed in our study population. Detailed analysis showed that both groups had equivalent doses of immunosuppressants and oral hypoglycemic agents. The odds ratio for hypoglycemia in the group treated with isophane compared to that treated with glargine was 0.224 (95% CI, 0.032–1.559). Glargine users recorded significantly lower blood sugar levels before lunch, dinner and at bedtime with p-values of 0.001, 0.009 and 0.001 respectively. A better hemoglobin A1c (HbA1c) level was seen in the glargine vs. isophane group (6.98 ± 0.52 vs. 7.45 ± 0.49, p-value 0.03). The study shows better blood sugar control with long-acting insulin analog, glargine, than with intermediate-actin analog, isophane. Overall, a higher number of hypoglycemic episodes was nocturnal. Long term safety of long-acting insulin analogs needs to be further studied." @default.
• W4362637893 created "2023-04-07" @default.
• W4362637893 creator A5017474506 @default.
• W4362637893 creator A5021982214 @default.
• W4362637893 creator A5028218294 @default.
• W4362637893 creator A5063376955 @default.
• W4362637893 date "2023-06-01" @default.
• W4362637893 modified "2023-09-27" @default.
• W4362637893 title "Hypoglycemia with insulin in post-transplant diabetes mellitus" @default.
• W4362637893 cites W2026778629 @default.
• W4362637893 cites W2035881307 @default.
• W4362637893 cites W2278471634 @default.
• W4362637893 cites W2770096185 @default.
• W4362637893 cites W2801298732 @default.
• W4362637893 cites W3133553555 @default.
• W4362637893 doi "https://doi.org/10.1016/j.trim.2023.101833" @default.
• W4362637893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37024062" @default.
• W4362637893 hasPublicationYear "2023" @default.
• W4362637893 type Work @default.
• W4362637893 citedByCount "0" @default.
• W4362637893 crossrefType "journal-article" @default.
• W4362637893 hasAuthorship W4362637893A5017474506 @default.
• W4362637893 hasAuthorship W4362637893A5021982214 @default.
• W4362637893 hasAuthorship W4362637893A5028218294 @default.
• W4362637893 hasAuthorship W4362637893A5063376955 @default.
• W4362637893 hasConcept C126322002 @default.
• W4362637893 hasConcept C134018914 @default.
• W4362637893 hasConcept C156957248 @default.
• W4362637893 hasConcept C2778537899 @default.
• W4362637893 hasConcept C2779306644 @default.
• W4362637893 hasConcept C2779920387 @default.
• W4362637893 hasConcept C2780668416 @default.
• W4362637893 hasConcept C555293320 @default.
• W4362637893 hasConcept C71924100 @default.
• W4362637893 hasConcept C90924648 @default.
• W4362637893 hasConceptScore W4362637893C126322002 @default.
• W4362637893 hasConceptScore W4362637893C134018914 @default.
• W4362637893 hasConceptScore W4362637893C156957248 @default.
• W4362637893 hasConceptScore W4362637893C2778537899 @default.
• W4362637893 hasConceptScore W4362637893C2779306644 @default.
• W4362637893 hasConceptScore W4362637893C2779920387 @default.
• W4362637893 hasConceptScore W4362637893C2780668416 @default.
• W4362637893 hasConceptScore W4362637893C555293320 @default.
• W4362637893 hasConceptScore W4362637893C71924100 @default.
• W4362637893 hasConceptScore W4362637893C90924648 @default.
• W4362637893 hasLocation W43626378931 @default.
• W4362637893 hasLocation W43626378932 @default.
• W4362637893 hasOpenAccess W4362637893 @default.
• W4362637893 hasPrimaryLocation W43626378931 @default.
• W4362637893 hasRelatedWork W1971493468 @default.
• W4362637893 hasRelatedWork W2013339698 @default.
• W4362637893 hasRelatedWork W2053042303 @default.
• W4362637893 hasRelatedWork W2077148563 @default.
• W4362637893 hasRelatedWork W2100084585 @default.
• W4362637893 hasRelatedWork W2119954342 @default.
• W4362637893 hasRelatedWork W2126781806 @default.
• W4362637893 hasRelatedWork W2357347625 @default.
• W4362637893 hasRelatedWork W2365093310 @default.
• W4362637893 hasRelatedWork W4386901692 @default.
• W4362637893 hasVolume "78" @default.
• W4362637893 isParatext "false" @default.
• W4362637893 isRetracted "false" @default.
• W4362637893 workType "article" @default.